IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

Stock futures edged higher on Thursday as investors reacted to Nvidia's (NVDA) strong earnings, while initial jobless claims ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and ...